- Home
- RDIB vs NRC Comparison
RDIB vs NRC Comparison
Compare RDIB & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDIB
- NRC
- Stock Information
- Founded
- RDIB 1937
- NRC 1981
- Country
- RDIB United States
- NRC United States
- Employees
- RDIB N/A
- NRC N/A
- Industry
- RDIB Movies/Entertainment
- NRC Biotechnology: Commercial Physical & Biological Resarch
- Sector
- RDIB Consumer Discretionary
- NRC Health Care
- Exchange
- RDIB Nasdaq
- NRC Nasdaq
- Market Cap
- RDIB 259.2M
- NRC 278.8M
- IPO Year
- RDIB N/A
- NRC N/A
- Fundamental
- Price
- RDIB $10.97
- NRC $14.50
- Analyst Decision
- RDIB
- NRC
- Analyst Count
- RDIB 0
- NRC 0
- Target Price
- RDIB N/A
- NRC N/A
- AVG Volume (30 Days)
- RDIB 4.0K
- NRC 98.9K
- Earning Date
- RDIB 11-12-2025
- NRC 10-27-2025
- Dividend Yield
- RDIB N/A
- NRC 4.42%
- EPS Growth
- RDIB N/A
- NRC N/A
- EPS
- RDIB N/A
- NRC 0.71
- Revenue
- RDIB $219,213,000.00
- NRC $139,102,000.00
- Revenue This Year
- RDIB $6.85
- NRC N/A
- Revenue Next Year
- RDIB $10.86
- NRC N/A
- P/E Ratio
- RDIB N/A
- NRC $20.71
- Revenue Growth
- RDIB 7.59
- NRC N/A
- 52 Week Low
- RDIB $5.78
- NRC $9.76
- 52 Week High
- RDIB $14.95
- NRC $21.64
- Technical
- Relative Strength Index (RSI)
- RDIB 44.30
- NRC 66.47
- Support Level
- RDIB $11.23
- NRC $13.14
- Resistance Level
- RDIB $12.21
- NRC $14.18
- Average True Range (ATR)
- RDIB 0.33
- NRC 0.71
- MACD
- RDIB -0.02
- NRC 0.34
- Stochastic Oscillator
- RDIB 37.69
- NRC 89.64
About RDIB Reading International Inc Class B
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.